<DOC>
	<DOCNO>NCT01941615</DOCNO>
	<brief_summary>Investigate effect multiple oral dos BI 207127 + faldaprevir ( FDV ) multiple dose pharmacokinetics ethinylestradiol levonorgestrel ( MicrogynonÂ® ) healthy premenopausal female volunteer .</brief_summary>
	<brief_title>Effect BI 207127 + Faldaprevir Blood Levels Oral Contraceptives Containing Ethinylestradiol Levonorgestrel</brief_title>
	<detailed_description />
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Ethinyl estradiol , levonorgestrel drug combination</mesh_term>
	<mesh_term>Ethinyl Estradiol-Norgestrel Combination</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<criteria>Inclusion criterion : Healthy female subject Age 18 35 year ( inclusive ) Body Mass Index 2029.9 kg/m2 Use hormonal contraception ( i.e . oral contraceptive , hormonal contraceptive vaginal ring , hormonecontaining intrauterine device , depot injection contraceptive implant ) Exclusion criterion : Any relevant deviation healthy condition Subject assess investigator unsuitable inclusion , instance , consider able understand comply study requirement , condition would allow safe participation study Positive pregnancy test , pregnancy plan become pregnant within 1 month study completion , lactation Any relevant finding gynaecological examination Thrombotic predisposition accord thrombophilic test Existing history arterial thrombotic embolic process , condition predispose e.g . disorder clot process , valvular heart disease atrial fibrillation Existing history confirm venous thromboembolism , family history venous thromboembolism , know risk factor venous thromboembolism . Relevant varicosis No use additional contraceptive method screen examination 1 month last study drug administration ( acceptable method consider barrier method , sexual abstinence , nonhormonecontaining intrauterine device , vasectomisation male partner ) . Use hormonecontaining intrauterine device , depot injection contraceptive implant Any history relevant liver disease ( e.g . disturbance liver function , jaundice persistent itch previous pregnancy , DubinJohnson syndrome , Rotor syndrome , previous exist liver tumour ) AST ( aspartate transaminase ) and/or ALT ( alanine transaminase ) &gt; 1.5 ULN ( upper limit normal )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>